FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 01:21:10 25/05/2024 am IST | ||
| 2.43 EUR | +0.83% |
|
| Current month | -49.48% | ||
| 1 month | -50.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 2.43 | +0.83% |
| 23/24/23 | 2.41 | +4.78% |
| 22/24/22 | 2.3 | +6.48% |
| 21/24/21 | 2.16 | -2.70% |
| 20/24/20 | 2.22 | -0.45% |
Delayed Quote Deutsche Boerse AG
Last update May 25, 2024 at 01:21 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ3K5V |
| ISIN | DE000SQ3K5V2 |
| Date issued | 31/10/2022 |
| Strike | 266.5 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.5 € |
|---|---|
| Lowest since issue | 2.06 € |
| Spread | 0.02 € |
| Spread % | 0.82% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
